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The molt cycle in decapod crustaceans, including the blue crab, Callinectes sapidus, is 
supressed by the crustacean hyperglycemic hormone (CHH) neuropeptide family and 
stimulated by ecdysteroids (Ecds).  The Ecds are thought to act on both eyestalk ganglia 
(ES) and Y-organs (YO) where the CHH neuropeptides and Ecds are synthesized, 
respectively.  Since the resultant responses of Ecds are mediated through their nuclear 
receptors: ecdysone receptor (EcR) and retinoid-X receptor (RXR), the temporal 
expression of EcR-RXR in ES and YO during the molt cycle may reveal the regulatory 
role of Ecd on the activity of these two organs.  In this study, the full-legnth cDNA 
sequences of C. sapidus EcR1a and RXR1, and the coding region of three other isoforms 
of EcR and RXR, were isolated.  Moreover, temporal distributions of C. sapidus specific 
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1.  CHAPTER 1.  INTRODUCTION 
 
1.1.  The blue crab, Callinectes sapidus 
  
Blue crabs, Callinectes sapidus are classified into the Phylum Arthropoda, 
Subphylum Crustacea, Class Malacostraca, Order Decapoda, and Family Portunidae.  
The life cycle of C. sapidus continues through 27 to 29 cycles: molting from hatching to 
adulthood (Fig.1) [1], as each molt increases 30-50% of the body size.  Females undergo 
the terminal-pubertal molt and halt molting during the active reproductive period, while 
males continue to molt during their adulthood.  
 
 






1.2.  Molt stages and physiological changes 
Molting is the shedding process that is required for somatic growth and 
reproduction in animals belonging to the Phylum Arthropoda.  During the molt cycle, 
physiological and structural changes are closely related to molt stages, and molting can 
be classified into four different stages: intermolt (C4), premolt (D0-4), ecdysis (E), and 
postmolt (A-C3).  Premolt can be further characterized into three stages: early premolt 




Figure.2.  A schematic diagram of the molt cycle of C. sapidus with associated pheotypic 
changes of the swimming leg.  Inner ring: blue= premolt, yellow= ecdysis, and light blue= 
postmolt; outer ring: color represents the progression of molting: blue= intermolt (C4), magenta= 




Normal activities such as eating and swimming occur during intermolt when the 
exoskeleton is completely rigid, and the membranous tissue is attached to the hypodermis 
and the cuticle [4].  During premolt, the old cuticle is detached from the hypodermis by 
actions of digestive enzymes (chitinases) secreted by epithelial cells [5], and new cuticles 
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composed of an organic matrix are laid.  While the new cuticle is continuously formed, 
organic materials from the old one are reabsorbed, resulting in a breakable shell.  The 
ecdysis begins through the breakage of the ecdyseal line assisted by the hydrostatic 
pressure that is generated by the water uptake induced by the release of gut borne 
crustacean hyperglycemic hormone  [6,7].  After tanning and calicification during 
postmolt (A, B, C1-C3 stages), the animals resume normal activities.  
 
1.3.  Hormonal regulation of molting in crustaceans 
The molt cycle is regulated by an interaction between neuropeptide and steroid 
hormones, i.e. molt-inhibiting hormone (MIH)/crustacean hyperglycemic hormone 
(CHH) and ecdysteroids (Ecds), respectively.   
 
1.3.1  Neuropeptide hormone family (MIH/CHH)  
MIH and CHH are members of the CHH neuropeptide family, consisting of  72 to 
83 amino acids (aa) and containing six residues of Cys that form three intra-disulfide 
bridges [8,9].  MIH/CHH and their respective peptides are synthesized in neurosecretory 
cells in the medulla terminalis of the eyestalk ganglia (ES).  These neuropeptides are 
transported through the axonal tract and stored in the sinus gland (SG).  The stored 
neuropeptides are secreted into the hemolymph whereupon they suppress activities of the 
Y-organs (YO).  Since YO is the ecdysteroid (Ecd) synthesizing organ, the suppression 
of YO by MIH/CHH results in reduction of Ecd synthesis and secretion.  The inhibitory 
actions of MIH/CHH on the activity of the YO during the molt cycle have been studied in 
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several decapod crustaceans including Carcinus maenas, C. sapidus, Gecarcinus 
lateralis, Procambarus clarkii, and Uca pugilator [10-22] 
Compared to the effects of MIH/CHH on the YO during the molt cycle, the 
regulation of these neuropeptide expressions is not fully defined.  A previous study of the 
Cancer anternarius showed the effects of Ecds on MIH synthesis and secretion [23].  The 
extract of ES obtained from Ecd-injected crabs and ES-cultured media had greater effects 
to suppress the activities of the YO in vitro.  In addition, Hopkins [11] found that Ecds 
were concentrated in ES and the levels were higher than those in the hemolymph, 
indicating that Ecds may have interactions on the ES and stimulate MIH/CHH synthesis 
[22,24].  In genetic compartmentalization of MIH and mandibular organ-inhibiting 
hormone (MOIH) genes in Cancer pagurus, the up-stream promoter region of both of 
these genes contained ordered putative binding sites of the following transcription 
factors: chronic factor-1 (CF1), a homolog of retinoid-X receptor (RXR)/ultraspiracle 
(USP), and broad-complex factor (BR-C).  Furthermore, a study of MIH/CHH activities 
during the molt cycle of C. maenas showed that both CHH and MIH transcripts were 
slightly higher, although not significant, at the premolt than those at the intermolt stage 
[25].  Altogether, these findings indicate there may be some crosstalks between Ecds and 
neuropeptide hormones in order to regulate the molt cycle.   
 
1.3.2.  Ecdysteroid hormones 
 Ecdysteroids are a class of steroid hormones that is derived from cholesterol and 
present in animals, plants, and fungi [26- 31].  Ecds play important roles in several 
processes, especially in molting.  For insects, 20-hydroxyecdysone (20-HE) is the major 
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form, while other Ecds can be synthesized depending on the precursors present.  Ecds in 
crustaceans are generated in the YO in four major forms depending on the species, 
including ecdysone (E), 3-dehydroxyecdysone (3DE), 25-deoxyecdysone (25-dE), and 3-
dehydro-25-deoxyecdysone (3D25dE) [32-36], as shown in Table.1.  In the peripheral 
tissues, these compounds are modified by 3β-reductase, 20-hydroxylase and 25-
hydroxylase to an active form [35].  
 
Table 1.  Major Ecd secreted by the Y-organs of decapod crustaceans (Mykles, 2011) 
 
 
1.3.2.1.  Ecdysteroids and the molt cycle 
 It is accepted that molting is induced by Ecds, and molt stages are correlated and 
defined by Ecd titers [14,37-42].  During the molt cycle, Ecd titers flunctuate widely: low 
during postmolt and intermolt (C4), slightly increased during early premolt (D0), surging 
suddenly at D1, reaching a peak at D2, and dropping suddenly to the basal levels at D3/D4, 
as reported in Hyas araneu, Metopograpsus messor, C. magister, C. maenas, and 
C.sapidus as shown in Fig.3.  In addition, the clearance of Ecds in Homarus americanus, 
measured by percentage of radiolabeled 20-HE in the hemolymph and excretion after 
injection, is molt-stage dependent: lowest at early premolt (D0/D1), followed by mid 
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premolt (D2) and highest during post molt and intermolt [43].  Therefore, the levels of 
Ecds circulating in hemolymphs result from dynamic relationship between synthesis and 
degradation of Ecds. 
 
Figure.3.  Circulating Ecds from a C. sapidus female during the last two molts: pre-pubertal molt 
(-140 to -80) and adult molt (-80 to 0) assayed by Ecd-RIA. Numbers on the X-axis represents 





1.3.2.2.  Ecdysteroidogenesis and regulation of Y-organ activity 
 
 The YO are the Ecd synthesizing site located in the cephalothorax anterior to the 
branchial chamber.  Y-organ cells typically contain high levels of mitochondria and 
endoplasmic reticulum [34].  Arthropods synthesize Ecds from cholesterol that is carried 
by high-density lipoproteins (HDL) in the hemolymph and taken up by the YO.  This 
process, as an important, rate-limiting step, is controlled by CHH neuropeptides that 
decrease the cholesterol uptake by depressing the number of HDL receptors [34,35,44].   
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Ecdysteroidogenesis in the YO of crustaceans and the prothoracic glands of 
insects are similar, but the biosynthetic pathway in the former appears to be more 
complex and produces many forms of Ecds [35].  Ecdysteroidogenesis can be divided 
into two stages: 1) conversion of cholesterol to 5β-diketol by a series of enzymes; and 2) 
conversion of 5β-diketol to the secreted products by four different pathways.  Among the 
key enzymes involved in stage 2, cytochrome P450 monooxygenases (P450) encoded by 
the phantom gene or Cyp306a1 in decapods [45] are a target for suppression by 
neuropeptide hormones.  Transaldolase, an enzyme involve in production of NADPH 
(coenzyme of P450), is translationally suppressed by MIH [13].  Therefore, CHH 
neuropeptides may suppress ecdysteroidogenesis in the YO through reducing HDL 
uptake and/or activities of Ecd-synthesizing enzymes. 
 A recent study by Chung [1] reports that, at the premolt stage of C. sapidus, 
ponasterone A (PonA) is the major form followed by 20HE, while 3DE and 25-dE are the 
minor forms (Fig. 4).  Moreover, it appears that Ecd ratios in three molt cycles vary in the 
ratios of 20HE: PonA.  This ratios increase with each successive molt: from 0.25 to 0.44, 
although the functional significance of the changes in the ratios between these two Ecds 





Figure.4.  Different forms of Ecds from hemolymph during mid premolt (D2) from juvenile 
(black bar), pre-pubertal (light-grey bar), and adult (grey bar) molts, assayed by HPLC-RIA.  % 
Ecd represents percentages of 20-hydroxyecdysone (20-OH E), ecdysone (E), 3-
dehydroxyecdysone (3 dehydro E), Ponasterone A (PoA), 25-deoxyecdysone (25 deoxy E), and 
unknown from total Ecds [1]. 
 
 
1.4.  Nuclear hormone receptor superfamily 
 Ecdysteroids bind to a heterodimer EcR/RXR complex, both of which belong to 
the superfamily of nuclear receptors (NRs) known for hydrophobic molecules such as 
steroid hormones, retinoic acids (all trans and 9-cis isoforms), thyroid hormones, fatty 
acids, leukotrienes, and prostaglandins [46].  The NRs are phylogenetically related 
proteins and are commonly found from sponges, echinoderms, tunicates, arthropods, to 
vertebrates [47].  The NRs are characterized by five independent functional domains (A-
F; originally defined by Krust [48]; 1) N-terminal A/B domains or activation function-1 
(AF1), 2) C or DNA-binding domain (DBD), 3) D or hinge region (HR) domain, 4) E or 
ligand-binding domain (LBD), and 5) C-terminal F or AF2 domain [49,50] as shown in 






 Each domain has a specific function: 1) AF1 displays ligand-independent 
transactivation; 2) DBD binds to regulatory elements (REs) of the target genes; 3) HR 
provides flexibility within the molecule; 4) LBD serves as docking sites for its cognate 
ligands and transcriptional regulators (coactivator or corepressor); and 5) AF2 exhibits 
ligand-dependent activation.  Since NRs contain DBD and AF domains in the same 
molecule, the NR superfamily can directly transactivate their target genes upon the 
binding of cognate ligands [51].  The NRs exhibit a highly conserved DBD in which two 
zinc-finger motifs are located and are responsible for binding to the hormone responsive 




   
 
Figure.5.  Schematic illustration of the structural and functional organization of nuclear 
hormone receptor family.  The evolutionarily conserved regions C and E are indicated as white 
and grey boxes, respectively, while the line represents the divergent regions A/B, D, and F. 
Two transcription activation functions (AFs) have been described: a constitutively active AF1 
in the A/B region and a ligand-inducible AF2 in region E or F. AD: autonomous transactivation 
domain, DBD: DNA binding domain, HR: hinge region, LBD: ligand binding domain, NLS: 




1.4.1.  Transcriptional regulations by nuclear receptors  
 
The molecular mechanisms of NRs upon ligand binding are similar in that 
conformational changes trigger a cascade of events.  The localization of NRs also has an 
effect on transcriptional activities.  In cytosol-localized NRs, binding to a ligand results 
in the dissociation of a chaperone followed by translocation into the nucleus and 
formation of a homodimer with their REs.  Ligand binding to the nuclear-residing NRs 
stabilizes the dimer on its REs [28].  The ligand-receptor complexes on HREs will recruit 
coactivators that have histone acetytransferase (HAT) activities, resulting in local 
chromatin remodeling.  Subsequently, TATA-binding protein (TBP)-associated factors 
(TAFs) will target the TBP and TFIIB on the TATA-box, stabilize the formation of pre-
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initiation complex, and position general transcription factors and RNA polymerase II on 
the core-promoter (Fig.6.) [28,52].   
 
 
Figure.6.  Simplified models of transactivation by heterodimerizing (A) or homodimerizing 
receptors (B) A: 1) unliganded vitamin-D receptor (VDR) weakly associates with retionoid-X 
receptor (RXR) and binds non-specifically to DNA [55]. Upon binding to its ligand, a strong 
heterodimer is formed and binds to its direct repeat VDRE.  2) Conformational changes in LBD 
allow the AF2 domain to recruit coactivators: SRC-1, DRIPs 3) With HAT activity in some 
coactivators, chromatin remodeling is catalyzed. 4) TAFs are attracted to TBP/TATA.  5) Binding 
of TFIIB and DRIPs stabilizes preinitiation complex (PIC). 6) Transcription initiation by RNA 
polymerase II is initiated at the core promoter.  B:  1) Unliganded monomer (GR) associates with 
chaperones in cytosol.  2) Upon binding to the cognate ligand, GR is translocated into the nucleus 
and forms homodimer on its palindromic GREs. Conformational changes in AF1 and AF2 
domains promote series of events (3-6) as described in (A) [28].  
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1.4.2.  Subcellular localization of Ecdysone receptor (EcR) and 
retinoid-X receptor (RXR) 
 
 As members of the NR superfamily, both EcR and RXR/USP contain a nuclear 
localization signal (NLS) and/or a nuclear export signal (NES) that determine whether 
they are localized in the cytosol or the nucleus [56].  NLS is located in the D-domain 
adjacent to the second zinc-finger motif [57].  Each NR is regulated differently for 
nuclear transport and can be categorized as: 1) exclusively cytoplasmic, 2) both 
cytoplasmic and nuclear, and 3) exclusively nuclear [57,58].  EcR and RXR/USP have 
differential distributions; RXR/USP is found exclusively in the nucleus, while EcR will 
be translocated into the nucleus which subsequently heterodimerizes to its partner, 
USP/RXR, in the presence of its ligand [56,57].  
 
 
1.5.  Post-transcriptional controls in eukaryotic messenger RNA  
 The central dogma of genetic codes states that DNA gives rise to RNA followed 
by protein synthesis [59].  However, recent data shows that the flow of genetic 
information is not as simple as proposed initially.  Genetic regulations after post-
transcription also play important roles in the control of gene expressions as shown in 
Fig.7 [60-67].  In general, post-transcriptional modifications are as follows: 1) a 5´cap is 
added to the nascent pre-mRNAs after transcription initiation; 2) spliceosomes assemble 
and introns are spliced out from pre-mRNAs; and 3) a specialized 3´end is generated by 
cleavage and polyadenylation.  After the pre-mRNA has been fully processed to mature 
mRNA, the ribonuceloproteins will be complexed with export proteins for transporting 
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into the cytosol [64,68].  Furthermore, a steady state level of mRNAs will be determined 
by mRNA localization, turnover, and surveillance [63,65]. 
 
 
Figure.7.  A Schematic diagram of genetic regulations: regulatory processes are listed 
corresponding to transcriptional, post-transcriptional, and post-translational controls [64].   
 
  
Unlike prokaryotes, eukaryotic mRNAs also contain 5´ and 3´ untranslated regions 
(UTR) that serve as cis-regulatory elements (cis-REs).  Decoding nucleotides to amino 
acids (aa) during translation requires energy. Therefore, cells will tune translation of the 
transcripts according to their physiological needs [64].  In general, translation initiation of 
mRNAs can be modulated globally or specifically [64,69].  In the former, translational 
control is tuned by reversible modifications of general translation factors by 
phosphorylation [63,64].  For the latter, translational regulation is managed through cis-
REs.  For most well-characterized regions, cis-REs are normally present in either the 5´ 




1.5.1.  5´untranslated region (5´UTR) 
 cis-REs located in the 5´UTR influence translation rates (Fig.8.).  The majority of 
eukaryotic mRNAs have 20-100 nucleotides in their 5´UTRs.  However, unusually long 
5´UTRs containing upstream AUGs, uORFs and/or secondary structure will affect 
translation efficiency during translation initiation [69,70].  Interestingly, these cis-REs 
are often found in mRNAs encoding proto-oncogenes, transcription factors, growth 








Figure.8.  A structural organization of eukaryotic mRNA and the possible elements of 
translational regulation through various trans-acting factors: 5´-m7G, cap structure; eIF, 
eukaryotic initiation factor; CPE, cytoplasm polyadenylation element; EDEN, embryonic 
deadenylation signal; DICE, differential control element; PABP, poly(A)-binding protein. [?], 
possible sites of interaction of transacting factors (yet unknown) in the coding sequence. Regions 
of the mRNA involved in subcellular localization and stability are also indicated [72].  
  
 
1.5.1.1.  Upstream open reading frame (uORF) 
 Messenger RNAs containing uORFs are often up-regulated in their translations 
under stress or starvation condition, while the translations of other mRNAs are down-
regulated by the phosphorylated Eukaryotic Initiation Factor 2 (eIF2) [64].  For example, 
the GCN4 gene in yeast, encoding a master transcriptional activator for aa-biosynthesis 
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genes, is translated when eIF2 activity decreases.  Reducing the levels of ternary 
complexes (Met-tRNAi
Met
 and eIF2-GTP) will slow the reinitiation on four upstream 
uORFs and allow the 40S preinitiation complex to scan through the encoding ORF of the 
GCN4 gene.  As a result, the GCN4 gene is translated during the starvation (Fig.9.).   
 
Figure.9.  Translational regulation of GCN4 by upstream open reading frames (uORFs).  With 
low levels of eIF2α-phosparylation and abundant active ternary complex, ribosomes initiate 
translation at uORF1, resume scanning and reinitiate at uORF2, uORF3, or uORF4, but not at the 
start codon of GCN4.  When cells are starved for aa, eIF2α becomes phosphorylated and the 
number of active ternary complexes decreases.  As a result, reinitiation at uORF2-uORF4 occurs 






1.5.1.2.  Internal ribosome entry site (IRES) 
 During translation initiation, the 40S ribosomal subunit is recruited to the mRNA 
and positioned at the correct initiation codon by a series of intermolecular events 
involving a group of protein factors that assemble on the capped 5´ end of the mRNA 
[73].  Then, the recruited 40S ribosome will scan for the translation start site [74].  The 
translation initiation through this canonical pathway will be down-regulated under stress 
conditions.  Alternatively, some mRNAs contain a secondary or a tertiary structure at the 
5´UTR, called the internal ribosome entry site (IRES) that provides an alternative 
pathway for translation initiation.  Specific mRNAs containing IRES can be continuously 
translated when the cap-dependent mechanism is impaired as shown in Fig.10. 
[69,75,76].   
.  
Figure.10.  A schematic representation of cap-dependent (top) and HCV IRES-driven internal 






1.5.2.  3´untranslated region (3´UTR) 
 The 3´UTRs contain several highly conserved REs that are responsible for 
stability, translation efficiency, and spatial and temporal expression of mRNAs 
[61,63,65,77].  In addition, the 3´UTR also plays an important role in the control of 
variations in gene expression during early development when there is little or no 
transcriptional regulation [61].  In eukaryotes, translational initiation requires the 
formation of circular mRNAs that are generated by binding of the polyA-binding protein 
(PABP) and eIF4G at the 3´UTR and 5´UTR, respectively.  The 3´UTR also contains a 
signal for polyadenylation and serves as the binding sites for other translational 
regulators.  In general, nuclear-exported mRNAs will have 250 nts of poly (A) tail that 
will be slowly removed upon entering the cytoplasm [69].  Poly (A) tails less than 50 nts 
will decrease translation rate, while the longer tails, more than 200 nts, will stimulate 
translation [78].  This translational control is normally found in early development and 
oocyte maturation when transcription is absent.  Differential translation of maternal 
mRNAs is regulated in part through polyadenylation by 3´UTR cis-acting elements: 
cytoplasmic polyadenylation elements (CPE) and polyadenylation hexanucleotides 
(AAUAAA) [78,79].  These REs are bound by the CPE-binding protein (CPEB) and 
cleavage and polyadenylation specificity factor (CPSF), respectively [80,81].  
Polyadenylation is initiated by phosphorylation of CPEB to enhance the association 
between CPEB and CPSF.  As a result, poly(A) polymerase is recruited to the end of the 





Figure.11.  A schematic diagram of translational control by cis-regulatory elements in the 3´UTR 
through trans-factors: cytoplasmic polyadenylation element binding protein (CPEB) and cleavage 






2.  CHAPTER 2.  Molecular cloning ecdysone receptor (EcR) and 
retinoid-X receptor from the blue crab, Callinectes sapidus, and 
expression patterns in eyestalk ganglia and Y-organs 
 
Abstract 
 Crustacean molting is regulated by interactions between the levels of ecdysteroids 
(Ecds) and the crustacean hyperglycemic hormone (CHH) neuropeptide family including 
molt-inhibiting hormone (MIH) and CHH.  Ecds exert their signals through a 
heterodimer, nuclear receptor complex consisting of ecdysone receptor (EcR) and its 
partner, Ultraspiracle (USP)/retinoid-X receptor (RXR).  As an Ecd peak is recapitulated 
in each molt cycle during the life cycle of Callinectes sapidus, we undertook to gain a 
better understanding in the regulatory role of Ecds on molt cycle by isolating cDNAs of 
C. sapidus EcR and RXR (CasEcR and CasRXR).  Consequently, four structural isoforms 
of CasEcR and CasRXR cDNAs were isolated from eyestalk ganglia (ES) and Y-organs 
(YO).  The deduced amino acid (aa) sequences of four CasEcR and CasRXR isoforms 
consist of five structural domains that are typically found in nuclear receptors: 1) 
activation function-1 (AF1), 2) DNA binding domain (DBD), 3) hinge region (HR), 4) 
ligand-binding domain (LBD), and 5) AF2.  Four CasEcR isoforms are encoding 503-530 
aa residues and show variations in the HR with a 27-aa insert and the LBD with a 49-aa 
substitution.  On the other hand, the isoforms of CasRXRs with 399-449 aa residues are 
varied by a 5-aa and/or a 45-aa insert in the DBD and LBD, respectively.  It appears that 
expression levels of CasEcR and CasRXR isoforms are tissue-specific and molt-stage 
dependent in the ES and YO.  This indicates that different isoforms of CasEcR and 




2.1.  Introduction 
 Molting is the shedding process that is required for somatic growth and 
reproduction in animals belonging to the Phylum Arthropoda.  Molting control was first 
characterized in insects where it is stimulated by the molting hormone named 
ecdysteroids (Ecds) [26,27,83,84].  In crustaceans, molting is regulated by interactions 
between the hormones that act and counter-act: stimulation by Ecd and suppression by 
the neuropeptide hormone family named molt-inhibiting hormone (MIH) and the 
crustacean hyperglycemic hormone (CHH) [85-88].  Ecds are synthesized and released 
from Y-organs (YO), while MIH/CHH is produced in eyestalk ganglia (ES) [89-91].  
Although the inhibitory effects of MIH/CHH on ecdysteroidogenesis in the YO are 
established, regulation of MIH/CHH synthesis and release during the molt cycle still 
remains unknown [45,92,93].   
Ecd transduces its signal through a heterodimer complex consisting of the ecdysone 
receptor (EcR) and the retinoid-X receptor (RXR) [94-98].  EcR and RXR are members 
of the nuclear receptor (NR) superfamily [28,47,99-101].  The NR superfamily can 
directly transactivate the target genes upon the binding to cognate ligands [51].  Members 
of the nuclear hormone receptor family are characterized by their five independent 
functional domains (A-F; [48]: 1) N-terminal A/B domains or activation function-1 
(AF1), 2) C or DNA-binding domain (DBD), 3) D or hinge region (HR), 4) E or ligand-
binding domain (LBD), and 5) C-terminal F or AF2 domain [49,50,102].  The specific 
function of each domain is as follows: 1) AF1 possesses ligand-independent 
transactivation, 2) DBD binds to regulatory elements (REs) of the target genes, 3) HR 
provides flexibility within the molecule, 4) LBD serves as docking sites for its cognate 
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ligands and transcriptional regulators (coactivator or corepressor), and 5) AF2 has ligand-
dependent activation.  The NRs are highly conserved in the DBD containing two zinc-
finger motifs that are responsible for binding to the hormone responsive elements (HREs) 
[46,53,54,103].  In general, binding of the ligands to LBD renders conformational 
changes in the LBD and AF2, resulting in stabilization of dimerization or release of a co-
repressor.  
It has been proposed that Ecds may give a signal to the ES for MIH/CHH 
production [11].  The genetic compartmentalization of MIH in Cancer pagurus lists that 
he up-stream promoter region of MIH contains putative binding sites for transcription 
factors: chronic factor-1 (CF1), a homolog of RXR/ultraspiracle (USP), and broad-
complex factor (BR-C) [22,24].  Furthermore, MIH/CHH activities in the molt cycle of 
C. maenas showed that both CHH and MIH transcripts were slightly higher during the 
premolt stage [25].   
Overall, these data suggest that there may be some crosstalks between Ecds and 
neuropeptide hormones to control the molt cycle.  Specifically, Ecds may intimately 
regulate the levels of MIH/CHH in the ES through the EcR-RXR complex.  We aimed to 
examine this proposed model in Callinectes sapidus.  EcR and RXR cDNAs were 
isolated.  And, the levels of EcR and RXR transcripts were determined in ES and YO 




2.2.  Materials and methods 
2.2.1.  Animals and sample collection 
  Juvenile crabs of C. sapidus, (20-40 mm carapace width, CW) obtained from the 
blue crab hatchery at the Aquaculture Research Center [Institute of Marine and 
Environmental Technology (IMET), Baltimore, Maryland] were reared in individual 
compartments (15x15 cm) in a re-circulating closed artificial seawater system at 25 ppt 
salinity and 23-25 
o
C.  The animals were fed daily with chopped squid and monitored for 
their growth.  Animals with 70-90 mm CW were molt-staged initially [3].  The 
hemolymph (100ul) was withdrawn, while eyestalks (ES), and Y-organs (YO) were 
dissected and frozen immediately on dry-ice and kept at -80 
o
C until further use. 
 
2.2.2.  Total RNA extraction  
 Total RNA from collected tissues was extracted with QIAzol Lysis Reagent 
according to the manufacturer’s procedure (Qiagen, Maryland, USA).  In brief, tissues 
were lysed in 1 ml of QIAzol reagent, and 0.2 ml of chloroform was added for organic 
extraction.  After centrifugation at 14,000 g for 15 min at 4 
o
C, , the upper phase 
containing RNA was taken and mixed with isopropanol at a 1:1 ratio.  RNA was 
recovered by centrifugation at 14,000 g for 15 min at 4
o 
C.  The supernatant was 
discarded, and the pellet was washed with 70% diethyl pyrocarbonate (DEPC)-treated 
ethanol and air-dried.  The extracted RNAs were re-suspended in DEPC-treated water 
and quantified with a NanoDrop ND-1200 Spectrophotometer (NanoDrop Technologies, 




2.2.3.  Messenger RNA extraction from total RNAs 
  Total RNAs (10-100 µg) were used for mRNA extraction using the 
NucleoTrap® mRNA kit (BD Biosciences Clonetech, Mountain View, CA USA) in 
accordance with the manufacturer’s protocol.  In detail, the total RNA was adjusted to 1 
µg/µl with DEPC-treated water.  Oligo-dT beads were added and volume adjusted to 
reach 100 µg of total RNAs/15 µl, mixed, and denatured at 68 
o
C for 5 min.  The mixture 
was incubated at room temperature for 10 min, and briefly centrifuged at 2,000 x g for 15 
sec at 4 
o
C and at 11,000 x g for 2 min at 4 
o
C.  After discarding the supernatant, the 
pellet was washed with 3 volumes of buffer RM2 and gently mixed until it became milky.  
The suspension was transferred into a Nucleotrap Column and centrifuged under the 
same conditions as above.  After discarding the flow through, the column was washed 
with 5 volumes of buffer RM3, and the pellet was re-suspended by pipetting, and 
centrifuged under the same conditions as above.  The pellet was washed another time 
with buffer RM3 as described, and dry-centrifuged at 11,000 x g for 1 min at 4 
o
C.  The 
mRNA pellet was eluted with DEPC-treated water pre-warmed to 68 
o
C (20 µl/10 µl 
Oligo-dT beads), resuspended by pipetting until it became milky, incubated at 68 
o
C for 7 
min, and centrifuged at 11,000 g for 1 min at 4 
o
C.  The concentration of resultant 




2.2.4.  5´ and 3´ Rapid Amplification of cDNA ends (RACE) 
  The 5´ and 3´RACE cDNAs were synthesized using a BD SMART
TM 
RACE 
cDNA Amplification Kit (BD Biosciences Clontech) and RevertAid
TM
 Reverse 
Transcriptase (Fermentas). For 5´RACE, 1 µg mRNA, 1 µl random primer (12 µM), and 
1 µl BD Smart II A Oligo (12 µM: 5´–
AAGCAGTGGTATCAACGCAGAGTACGCGGG–3´) were mixed and the volume was 
finalized to to 5 µl with DEPC-treated water.  For 3´RACE, 1 µg mRNA and 1 µl of 
3´CDS primer (12 µM: 5´–AAGCAGTGGTATCAACGCAGAGTAC(T)30VN–3´) were 
mixed and the volume was finalized to 5 µl with DEPC-treated water.  The RNA 
mixtures were incubated at 70 
o
C for 2 min and cooled on ice for 2 min.  The mixture was 
added 4 µl of 5X Reaction Buffer, 0.5 µl of RiboLock
TM
 RNase Inhibitor (20 U), 2 µl of 
dNTP mix (10 mM), and 1 µl of RevertAid
TM
 Reverse Transcriptase (200 U) and the 
volume was finalized to 20 µl with DEPC-treated water.  After gentle mixing, the 
reaction was incubated at 42 
o
C for 1 h and terminated by incubation at 70 
o
C for 10 min.   
 
2.2.5.  Design of degenerate primers for cloning the full-length 
cDNAs of CasRXR and CasEcR  
 
  Degenerate primers of RXR (listed in Table 2) were designed based on the 
conserved regions identified from the multiple alignment (ClustalW: www.genome.jp) of 
crustacean RXR sequences including Carcinus maenas (ACG63787.1, ACG63788.1), 
Gecarcinus lateralis (AAZ20371.1, AAZ20368.1), Celuca pugilator (AAC32789.3), and 
Marsupenaeus japonicus (BAF75376.1).  The first EcR sequence of C. sapidus was 




2.2.6.  PCR with degenerate primers and 5´ and 3´RACE cDNA 
 
 The initial RXR sequence was obtained from a two-step PCR assay with degenerate 
primers [104].  In brief, a touch-down (TD) PCR was carried out with 3´RACE cDNA 
from the YO and RXR-dF1 primers and universal primers (UPM) with an Advantage Taq 
Polymerase (BD Biosciences).  Annealing temperatures at 47 °C, 45 °C, and 43 °C were 
used for 3 cycles with extension at 68 °C, for 1 min, while the final annealing was 
achieved at 48 °C for 27 cycles.  The TD products were diluted 20-fold in sterilized 
deionized water and used for the nested PCR with RXR-dF2 and RXR-dR1 primers with 
annealing at 50 °C and extension for 1 min at 68 °C.  After electrophoresis, the PCR 
product with the expected size was excised using the QIAquick Gel extraction kit 
(QIAgen).  The remaining procedures for cloning and sequencing were performed as 
described previously [104].  Based on these results from the initial sequence of CasRXR1, 
gene specific primers (RXR-5R1, RXR-5R2, RXR-3F1, and RXR-3F2) were produced 
for 5´ and 3´ RACE of CasRXR, respectively (Table. 2).   
 The full-length cDNA sequence of CasRXR1 was obtained from 5´and 3´ RACE.  
For the remaining isoforms, primers specific to the start and the end of open reading 
frame (ORF): CasEcR with EcR-3Fi and EcR-Rend primers; and CasRXR with RXR-3Fi 
and RXR-Rend primers, were amplified using a high-fidelity Taq polymerase (Clontech).  





Table. 2.  Lists of primer sequences used for cloning of RXR and EcR.  
Primers Primer Sequence (5´-3´) Tm (oC) 
RXR primers   
RXR dF1 GGNAARCAYTAYGGNGTNTA               54.3 
RXR dF2 TGYGARGGNTGYAARGGNTT 62.5 
RXR dR1 TCNARRCAYTTNARNCCDAT 55.3 
RXR dR2 AARTGNGGDATRTGYTTNGCCCA 67.4 
RXR 3Fi CTGGTGGCAGTGTTTCCCGAAGAGA 62.7 
RXR 3F1 CACCATCGACAAGAGACAGAGGAA 65.0 
RXR 3F2 AGGAACGTCAGAGGACAAAAGGTG 64.9 
RXR 5R1 TATTGCTTACCACATCCCCTTGGT                        64.7 
RXR 5R2 AGATAGCGCCACAGGAGGACTCT 64.9 
RXR 5Rend CTAGCTGGTGGGGGAGGTGTTGCT 65.1 
EcR primers   
EcR start AGAGCCGCCGCGTCTCAGTGT 66.7 
EcR Fi ATGTTTGTGTTGGGCTCTGGTGTGG 61.8 
EcR 3F1 ATGAGTCCTCCGACCTCCCTGGCC 73.3 
EcR 5R1 GCAACCAGCAACATCCCAGATCTC 68.2 
EcR Rend ATATGGCACCCAGGAGGTGGC 61.9 
 
“d” represents degenerate primers. Forward primers are designated with “F” and used for 3´ 
RACE, while reverse primers are coded with “R” and used for 5´RACE. 
 
 
2.2.7  Spatial distributions of C. sapidus EcR and RXR  
  ES and YO collected from the animals at molt stages C4, D0, D1, D2, and D3/4 
were extracted for total RNAs, subsequently treated with DNase I, and used for cDNA 
synthesis [104].  Sample cDNAs, each containing 12.5 ng of total RNA, were amplified 
with a combination of primers (Table. 3) for each isoform of CasEcR (CasEcR1: F-R, 
CasEcR2: F-R, CasEcR1a: F-R, CasEcR2a: F-R, and CasEcRt: F-R) and CasRXR 
(CasRXR1: F-R, CasRXR2: F-R, CasRXR1a: F-R, CasRXR2a: F-R, and CasRXRt: F-R) 
by using GoTaq® Green Master Mix (Promega) with an annealing temperature at 58 °C 
and extension at 72 °C, 30 sec for 33 cycles.  The expression of arginine kinase (AK) was 
determined in the same sample cDNA as a reference gene [104].  PCR products were 
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visualized by staining with ethidium bromide after electrophoresis on a 1.5% agarose gel 
and documented using a Kodak Gel Logic 200 Imaging system. 
 
Table.3.  Lists of primer sequences used for screening CasEcR and CasRXR isoforms. 
 
Primers Primer sequences (5´-3´) Tm (oC) 
EcR1   
EcR1 F CGACTCGGATGCCAAGTTTAAACAC 58.3 
EcR1 R GAACCGGGCTGCTCGGAGCATCATG 65.7 
EcR2   
EcR2 F CAGGCACATAACCGAGATGACGATC 59.2 
EcR2 R GAACCGGGCTGCTCGGAGCATCATG 65.7 
EcR1a   
EcR1a F CACTCCTAGCATCGTTCAGACTCCT 59.6 
EcR1a R GGCATCCGAGTCGTCATCACTTATT 58.7 
EcR2a   
EcR2a F CACTCCTAGCATCGTTCAGACTCCT 59.6 
EcR2a R CATGTCACTTGTATCTTCACCATCG 55.7 
Total EcR   
EcRt F GCATTGTGTTTGGAAATACCTTGCC 57.4 
EcRt R GCCCTCAATGCATCGAGGTATATTT 57.2 
RXR1   
RXR1 F GAAGCGGTCCAGGAGGAACGTCAGA 64.0 
RXR2 R TATTGCTTACCACATCCCCTTGGT                        64.7 
RXR2   
RXR2 F CGGTCCAGGTAGGGGCAGTAGAGGA 65.0 
RXR2 R TTCCTCCTCTACTGCCCCTACCTGGAC 64.2 
RXR3   
RXR3 F GAAGCGGTCCAGGAGGAACGTCAGA 64.0 
RXR3 R GAACTTGACAATGGTTGACAAGCCTC 58.4 
RXR4   
RXR4 F CGGTCCAGGTAGGGGCAGTAGAGGA 65.0 
RXR4 R GAACTTGACAATGGTTGACAAGCCTC 58.4 
total RXR   
RXRt F TTCCCATAGAAGACCAAGTTGTATTA 59.41 
RXRt R CTGGGTTGAACAGGACAATGGCACG 62.2 
 
 
2.2.8.  Sequence analyses of C. sapidus EcR and RXR  
 The open reading frame (ORF) of CasEcR and CasRXR nucleotide sequences were 
identified by ORF Finder (http://www.ncbi.nlm.nih.gov/projects/gorf/).  Both the 
nucleotide and deduced aa sequences of CasEcR and CasRXR isoforms were aligned 
using ClustalW (http://align.genome.jp/).  The nucleotide sequences of CasEcR and 
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CasRXR isoforms were further analyzed for putative RNA regulatory elements in the 5´ 
and 3´ UTR using RegRNA (http://regrna.mbc.nctu.edu.tw/html/prediction.html) [105].  
Post-translational modifications including glycosylation and phosphorylation were 
predicted by YinOYang and NetPhos 2.0 Server (http://www.cbs.dtu.dk/services/), 
respectively.  
 For secondary-structure prediction, the aa sequences of CasEcR and CasRXR 
isoforms were analyzed by PREDATOR 2.1.2 [106].  The deduced aa sequences of 
CasEcR and CasRXR isoforms were formatted into PDB sequences using the Phyre 
program (http://www.sbg.bio.ic.ac.uk/Phyre
2
/, using hemipteran and T. castaneum as 
references [107]) before viewing by PyMol program (Version 1.2r3pre) for tertiary 
structure simulation.  A phylogenetic tree of the putative EcR and RXR/USP obtained 
from arthropods including the CasEcR and CasRXR isoforms were generated and 
presented as phylograms [108] (http://www.phylogeny.fr).  
 
2.3.  Results 
2.3.1.  EcR isolation from C. sapidus 
2.3.1.1.  Full-length sequences of EcR gene  
The full-length cDNAs of the four CasEcR isoforms obtained posess same 5´UTR 
(917 nt) and 3´UTR (759 nt), but have variations in the ORF (1,509 nt in 
CasEcR1/CasEcR2 and 1,590 nt in CasEcR1a/CasEcR2a) (Figs. 12 A-C).  The ORFs are 
predicted to encode the NR superfamily that displays the five putative conserved 
domains: AF1, DBD, HR, LBD, and AF2.  All putative CasEcR proteins share identical 
AF1 (141 aa residues), DBD (90 aa residues), and AF2 (3 aa residues).  However, the HR 
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and LBD are varied in each isoform where a 27-aa insert and a 49-residue substitution are 
located, respectively (Figs. 12 and 13).  Isoforms containing the 27-aa insert in HR 
(named as HR
i
) are designated with “a,” while those which have a variation in the LBD 
are referred as “1” or “2.” 
The 5´UTR of CasEcR analyzed by RegRNA appears to contain translational 
regulation sites with two internal ribosome entry sites (IRES) and two upstream open 
reading frames (uORFs).  Two IRES are located at C286-G366 and C505-C692 (underlined in 
Fig. 12 A), while two uORFs are located in different frames: uORF1 (A706-A777) and 
uORF2 (A913-A1,068) (highlighted in grey in Fig. 12 A).  Both uORF1 and uORF2 are 
located downstream of the second IRES, while uORF2 overlaps the major ORF (mORF).  
The uORFs are predicted to encode two short peptides: uORF1 with 6 aa residues 
(MALALT) and uORF2 with 51 aa residues 




(A)   
CasEcR1 (HQ630857) 
 
  1   AGAGTTGCCCGCCAGCCGTCGCCGGGTGAGCACCTCATCGCTCGTGTCCGCCTCTCTCCACTACGTTTCG 
 71   TGTCCTTCCTCGCGCGTGTTTCGTGCTTTACATTGACTCTTGAGTGCTGCAGTAAAAGAACACCTTGTCG 
141   CGTGTGACAACAATACGTATATTGTTGGCGACAACTTTCTTTTACTGTCAGAGAAACTTTGTCATTCCGT 
211   CGCGTTTGTTTTGTTGGTGCAAGAGAGTGCCGGACGCTATTGTAAGCCAAGTTTTTACTTACCTTTGATT 
281   CTTGACATTGGCTCAGTAACAGACAACCGCAGTCTCACGACCCCGCATCAGTTTAACCGATAACAAGACG 
351   TGTAAGATAAGATAAGTCACCAATAGTCCGTCGTTGTGAACGAGAGCCGCCGCGTCTCAGTGTTGGAGTG 
421   ACTGGCCTCGCGAGAGTTCCAGCGGCACACAAGGTCAAGTTCATTCGCCGCCTCCACCCCCGCACCGTTG 
491   TCCCTTCACTCCTTCATAAACTGCTATTGAACCTGTTGCTCGAGGAAAGCCAAGTGAAAGGAAAAGTTGC 
561   TTTCGACCTGACCTGGTAACCGACGCCATTTGACCCAAATACTACGCCACCCATTCACCAACACTGACAG 
631   GGCACACTTGACCTACACGAGCCACTCCACCACCACTACAGTGAGAGTGGGAGGAGCAGCACACACCCGC 
701   TGAAGATGGCTCTGGCCCTTACATAAGTGATCCAGAGTCATGACCTAAGATGAGCCCTGCTGAATACTAC 
771   CAATTGATCCTCGTGAACTCACCACCCACTACCAAGTGATCTATTGGACGGGCCATTGTTTCTCACGTGT 
841   GACAGTCAGTGGACGACGCGTGACGGCCGCCGCGCCAACGTTTGGCCAAAGTGCCGGCGACAGCGCGTGT 
911   CGATGGA 
 
    918 atgtttgtgttgggctctggtgtggccacactcaacctctccgccatgggggacgagagt 
        M  F  V  L  G  S  G  V  A  T  L  N  L  S  A  M  G  D  E  S  20  
    978 tgctccgaggtgtccagctcatcaccgctcaccagccctggtgccctctccccgccagca 
        C  S  E  V  S  S  S  S  P  L  T  S  P  G  A  L  S  P  P  A  40 
   1038 ctcgtcagcgtcggcgtcaacgttggcatgagtcctccgacctccctggcctcctcagac 
        L  V  S  V  G  V  N  V  G  M  S  P  P  T  S  L  A  S  S  D  60 
   1098 atcggcgaggtggacctggacttctgggatcttgatctcaactccccaagccccccacac 
        I  G  E  V  D  L  D  F  W  D  L  D  L  N  S  P  S  P  P  H  80 
   1158 ggcatggcatccatcgcttccaccaacgccctcttgctcaacccccgtgctatggcctca 
        G  M  A  S  I  A  S  T  N  A  L  L  L  N  P  R  A  M  A  S  100 
   1218 ccctccgacacctcctccctatcagggcgagatgacatgtcgccgccctcttcagtgggc 
        P  S  D  T  S  S  L  S  G  R  D  D  M  S  P  P  S  S  V  G  120 
   1278 aactacagcgccgattccttcggcgatctgaagaagaaaaaaggccccatccctcgccag 
        N  Y  S  A  D  S  F  G  D  L  K  K  K  K  G  P  I  P  R  Q  140 
   1338 caggaggaactgtgtttagtgtgcggggaccgggcgtcaggctaccaccacaatgcactc 
        Q  E  E  L  C  L  V  C  G  D  R  A  S  G  Y  H  H  N  A  L  160 
   1398 acctgcgagggatgcaaaggcttcttccgaagatccatcacaaagaatgctgtgtaccag 
        T  C  E  G  C  K  G  F  F  R  R  S  I  T  K  N  A  V  Y  Q  180 
   1458 tgtaaatatggtggcaactgtgaaatggacatgtacatgcgacgcaagtgtcaagagtgt 
        C  K  Y  G  G  N  C  E  M  D  M  Y  M  R  R  K  C  Q  E  C  200 
   1518 cgcctcaaaaagtgtcttggtgtgggcatgcgaccagaatgtgtcgtgccagagtctcag 
        R  L  K  K  C  L  G  V  G  M  R  P  E  C  V  V  P  E  S  Q  220 
   1578 tgcgtggtgaagagagagcagaagaagctacgagacaaggataagaaggactatccaagt 
        C  V  V  K  R  E  Q  K  K  L  R  D  K  D  K  K  D  Y  P  S  240 
   1638 caaggctccccagtagctgaggaaaaggccgttccaacaagtccaatgtcagccggggcc 
        Q  G  S  P  V  A  E  E  K  A  V  P  T  S  P  M  S  A  G  A  260 
 
   1698 agatcaaatgtcaaaccactcactcgagagcaggaggagctgatcaacacactagtctac 
        R  S  N  V  K  P  L  T  R  E  Q  E  E  L  I  N  T  L  V  Y  280 
 
   1758 taccaagaacagtttgaacagcctactgaagcagacatcaaaaagataagagattacgaa 
        Y  Q  E  Q  F  E  Q  P  T  E  A  D  I  K  K  I  R  D  Y  E  300 
   1818 ataagtgatgacgactcggatgccaagtttaaacacatcacagacatgaccatcctcaca 
        I  S  D  D  D  S  D  A  K  F  K  H  I  T  D  M  T  I  L  T  320 
   1878 gtgcagctgatcgtagagttctccaagcgcctgcccggctttgacacactactcagagag 
        V  Q  L  I  V  E  F  S  K  R  L  P  G  F  D  T  L  L  R  E  340 
 
   1938 gatcagattacactgctaaaggcttgctcatcagaagtcatgatgctccgagcagcccgg 
        D  Q  I  T  L  L  K  A  C  S  S  E  V  M  M  L  R  A  A  R  360 






        F  Y  D  A  K  T  D  C  I  V  F  G  N  T  L  P  Y  T  Q  T  380 
   2058 tcatatgagtttgctggcttgggagaatcatcacaaatactcttccgtttttgtcgcaac 
        S  Y  E  F  A  G  L  G  E  S  S  Q  I  L  F  R  F  C  R  N  400 
   2118 ctatgtaaaatgaaagttgataatgctgagtatgcacttctgtctgccataatcatattt 
        L  C  K  M  K  V  D  N  A  E  Y  A  L  L  S  A  I  I  I  F  420 
   2178 tcagagaggccaaacctaaaggaactccagaaggtggaaaagcttcaagaaatatacctc 
        S  E  R  P  N  L  K  E  L  Q  K  V  E  K  L  Q  E  I  Y  L  440 
   2238 gatgcattgagggcatacgtatgtaatcaaaggtttccccgacctggcatggtgtttgca 
        D  A  L  R  A  Y  V  C  N  Q  R  F  P  R  P  G  M  V  F  A  460 
   2298 aagttgcttaatatcctcactgagttacgaacccttggaaacttgaactcagaggtatgc 
        K  L  L  N  I  L  T  E  L  R  T  L  G  N  L  N  S  E  V  C  480 
   2358 ttctccctcaaactcaagaacaaaagactcccaccatttttggctgagatctgggatgtt 
        F  S  L  K  L  K  N  K  R  L  P  P  F  L  A  E  I  W  D  V  500 
   2418 gctggttgctga   
        A  G  C  *  503 
 
 2430 GCTTCAGCCACCTCCTGGGTGCCATATTACCGAGGTAAAATATTGGCGCAAGAAGGTTGTGAGCCCTTTG 
 2500 GGGGTGGTGGATGGACTCTACACTATGTACCTGTCGGCTGTAAGTGAGAGACTGTTGATGTTGTGGCAGC 
 2570 AGCTTCACACTGCCACCCCAGGGCCCACTTTCAGCCACCTGACGTGTTTATGGTTCAGGCCACCACTGTG 
 2640 ACAGTGCTGTGTAGCACTCTATTAGTGCAATGATAAGTGTATAATGATGCACTTTAGATGTGAAGGGCAG 
 2710 CAGTATGGGCATTGTAGCCATTTTTATTAACACATTTTATAAAACCTTCAGATATAATGAAAGTGGTGTG 
 2780 CATATGACTGTTTCATATACGTATACCTACATGTATGTGTAAAATGTTTTTTGCTATGTAATTTTTTTAT 
 2850 ATAATATTTAAAGTAAAAAGGGCTACATTGCACTGTTGTTCAGACACTGCGCAAGCCACATTTTGGCAGG 
 2920 CAACGAACTCCCCGTGCCTTGCTTACGGTCAAGCCTCTGTTTCCTACACTATTCTCAAGGTGCTCCTGCG 
 2990 GGACTGAGGAGAGGGGAATCTAAACACAAGGAACAGTGCGATGTCTTTTGATCCATATTTTTATATGAAT 
 3060 TCTTGTTAATTTAATGAGCTGGTATGCCGTCCTTACAAGTAGTAAACTATCGAAAATATATGTTAATATT 
 3130 ACTGTAATATTATTAATACTGCTATGAAATGTAAAAAAAAAAAAAAAAAAAAAAAAAAA 3188 
 
(B) 
+81-nt insert within HR
i
 of CasEcR1a (HQ630859) and CasEcR2a (JQ771939) isoforms 
 tgtaaatccaaaggtccatcacctgcatgtgatatgcagttcaaaaatcttgttgacact 
        C  K  S  K  G  P  S  P  A  C  D  M  Q  F  K  N  L  V  D  T   
        cctagcatcgttcagactcct 
        P  S  I  V  Q  T  P   
(C) 
147-nt substitution in CasEcR2 (HQ630858) and CasEcR2a 
 tttaacttcgatggtgaagatacaagtgacatgagattcaggcacataaccgagatgacg 
        F  N  F  D  G  E  D  T  S  D  M  R  F  R  H  I  T  E  M  T   
        atcctcacagttcagctcatagtggaattctccaagcaactaccaggtttcggcacactt 
        I  L  T  V  Q  L  I  V  E  F  S  K  Q  L  P  G  F  G  T  L   
        cagcgagaagaccagattaccctgctc 
        Q  R  E  D  Q  I  T  L  L 
 
 
Figure.12.  (A) Full-length sequence of CasEcR1 and its putative regulatory elements  
analyzed by RegRNA; grey hightlight = uORF; underline = IRES; bold underline = DBD and 
LBD; triangle = insertion in CasEcR1a/CasEcR2a isoforms (B), and arrows = nucleotide 
substitution in CasEcR2/CasEcR2a isoforms (C).  The numbers on the left designate the 




















Figure. 13. (A) Multiple alignment of deduced aa sequences of four CasEcR isoforms  
(ClustalW).  Blue and magenta alphabets are DBD and LBD, respectively.  A 49-aa substitution 
in the LBD of CasEcR1/CasEcR1a and CasEcR2/CasEcR2a is presented in orange and green, 
respectively. Glycosylation sites are highlighted in yellow (YinOYang), and phosphorylation sites 
are marked with hexagons (NetPhos 2.0 Server). (B) Schematic diagram shows variations in four 
isoforms regarding to structure compartmentalization.  
 
 
2.3.1.2.  Post-translational modification predicted in CasEcR  
 
The glycosylation sites predicted are marked in yellow in Fig. 13 A.  The AF1 
domain has the highest number of glycosylation sites: 16 residues in CasEcR1/CasEcR2 
and 15 residues in CasEcR1a/CasEcR2a, while the HR
i
 within CasEcR1a/CasEcR2a has 
one more glycosylation site than the HR of CasEcR1/CasEcR2.  The LBDs of all four 
isoforms show only one glycosylation site, whereas none is found in the DBD and AF2.    
The majority of predicted phosphorylation sites are found in the AF1 domain (17 aa 
residues, marked with hexagon in Fig. 13 A).  The insert fragment in HR
i 
of 
CasEcR1a/CasEcR2a provides three more sites, and the LBD of CasEcR1/CasEcR1a has 
one additional site compared to that of CasEcR2/CasEcR2a.  For the DBD, all four 
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CasEcR isoforms contain three phosphorylation sites at Y155, S172, and Y192, while none 
are found in the AF2 domain.  The number of the predicted sites in each domain of 
CasEcR is listed in Table.4. 
 
Table. 4  Post-translational modifications in CasEcR: O-linked glycosylation predicted by 
YinOYang 1.2 and phosphorylation predicted by NetPhos 2.0 Server 
(http://www.cbs.dtu.dk/services/) 
 
 Isoforms O-linked glycosylation (residues) Phosphorylation (residues) 
  AF1 DBD HR LBD AF2 AF1 DBD HR LBD AF2 
CasEcR1 16 0 2 1 0 17 3 5 8 0 
CasEcR2 16 0 2 1 0 17 3 5 7 0 
CasEcR1a 15 0 3 1 0 17 3 8 8 0 
CasEcR2a 15 0 3 1 0 17 3 8 7 0 
 
 
2.3.1.3.  Structural prediction and computational analysis of 
CasEcR isoforms 
 
When isoforms of CasEcR are analyzed for secondary structure within the encoding 
sequences by PREDATOR 2.1.2 [106], helices (H) and β-sheets (E) are formed in every 
domain except AF2 (see Table.5.).  The structural conformation of the AF1 domain is 
similar in all four isoforms, and the domain is predicted to form three sheets and one 
helix.  On the other hand, the DBD has number of β-sheet that  relate to the 27-aa 
insertion at the HR in which the CasEcR1/CasEcR2 has four sheets while 
CasEcR1a/CasEcR2a has five, but all isoforms have the same three helices.  On the HR 
itself, the inserted fragment has likely adopted one more sheet and helix as shown in 
CasEcR1a/CasEcR2a.  For the LBD, all four isoforms have four sheets but contain 
different helices.  However, none of the secondary structures are predicted to form in the 




Table. 5  Secondary structure of deduced aa sequences of CasEcR predicted by PREDATOR 
2.1.2.  H: helix, E: β-sheet, AF1: activation function-1, DBD; DNA-binding domain, HR: hinge 




AF1 DBD HR LBD 
AF2 
H E H E H E H E 
CasEcR1 1 3 3 4 1 - 7 4 - 
CasEcR2 1 3 3 4 1 - 8 4 - 
CasEcR1a 1 3 3 5 2 1 9 4 - 
CasEcR2a 1 3 3 5 2 1 9 4 - 
 
 
The computational analysis of the putative LBD of CasEcR1/CasEcR1a (D298-L338) 
and CasEcR2/CasEcR2a (F298-Q338) reveals that the variable residues are located in the 
ligand-binding pocket (LBP) and appear to have an effect on the hydrophobic field of the 
LBP (Figs. 14 A and B).  The simulated LBP of CasEcR2/CasEcR2a isoforms is more 






Figure.14.  Putative protein structure of CasEcR1 and CasEcR2 by PyMol program base on X-
ray crystallography of EcR-USP complex bound to ponasterone A of Heliothis virescens [107]. 
The Number in the structural compartment represents aa residues in each domain.  Variations in 
CasEcR1 and CasEcR2 are labeled in the ball-and-stick model (green and red representing 
hydrophobic and hydrophilic residues, respectively).  The legends in (A) and (B) represent 
surface model in variations of CasEcR1 and CasEcR2, respectively.  
 
 
2.3.1.4.  Relationship of arthropod EcRs  
The relationship of four putative CasEcR sequences were compared with other 
arthropod EcR sequences using human farnesoid X receptor (HosFXR) as an outgroup, 
which resulted in two clades: one for crustaceans and the other for insects (Fig. 15).  
CasEcRs are most closely related to C. maenas EcR and with Apis mellifica EcR among 





Figure.15.  A phylogram of ecdysteroid receptor (EcR) in arthropods generated by Phylogeny.fr: 
EcR homolog in human (HosFXR accession: AAH71778.1) is served as the outgroup.  A. 
aegyptii (AeaEcR: AAA87394.1), A. mellifica  (ApmEcR: NP_001152827.1, NP_001091685.2, 
BAF46356.1), B. mori (BomEcR: NP_001037331.2, NP_001166846.1, NP_001166848.1), C. 
sapidus (CasEcR: HQ630857, HQ630858, HQ630859, JQ771939), C. maenas (CamEcR: 
AAR89628.1), C. pugilator (CepEcR: AAC33432.2), C. crangon (CrcEcR: ACO44665.1, 
ACO44666.1, ACO44667.1), D. magna (DamEcR: BAF49032.1, BAF49033.1, BAF49030.1, 
ABP48741.1), D. melanogaster (DrmEcR: AAA28498.1), G. lateralis (GelEcR: AAT77808.1), 
H. americanas (HoaEcR: AEA29831.1), N. integer (NeiEcR: ACO92359.1, ACJ68423.1), T. 
japonicus (TijEcR: ADD82902.1), T. castaneum (TrcEcR: CAL25730.1).  The scale bar 






2.3.2.  Isolation of C. sapidus RXR cDNA  
2.3.2.1.  Full-length cDNA sequences of C. sapidus RXR  
 The full-length cDNA sequences of the four CasRXR isoforms obtained posess the 
same nucleotide sequence in the 5´UTR (181 nt) and the 3´UTR (209 nt) but have a 
different sized mORF ranging from 1,200 to 1,350 nt (Figs. 16 A-C).  Similar to CasEcR, 
the four putative CasRXR proteins contain five functional domains in the following 
order: AF1, DBD, HR, LBD, and AF2.  These four deduced CasRXR proteins have 
identical AF1 (71 aa residues), HR (20 aa residues), and AF2 (28 aa residues).  However, 
variations can be seen in the DBD and/or LBD with a 5- and/or a 45-aa insert, 
respectively (Figs. 16 and 17).  The 5-aa insert is positioned at the T-box of the DBD, 
where the dimerized interface with the DNA target sequence is located, (called DBD
T
), 
while the 45-aa insert generates a longer LBD (LBD
L
).  Therefore, four CasRXR 









).   
 Translational regulation sites were found in the 5´UTR of CasRXR, when it was 
analyzed by RegRNA.  Both an IRES and an uORF are predicted and located at A17-A88 
and T99-G184, respectively (Fig. 16).  The last 3 nt (ATG) of the IRES are overlapped 







  1   ACAGCGGCAGGCAGACATGAACGCTGGTGGTGGTCGGCCATGTTTATATTCTCTGTTTGTCAATAATCTC 
 71   TTCTAACTACCGATTTGACTAACATTTTTTTTTTACTCCGAACGTTACTTCCGCGGCGAGTGACAGCTGG 
141   TGGCAGTGTTTCCCGAAGAGAGTCCAGGTGTGGATATCGGC 
 
  182 atgtccggctccctggatcgccagtcccccctcagcgtggcgccagacaccgtgtccctc 
      M  S  G  S  L  D  R  Q  S  P  L  S  V  A  P  D  T  V  S  L  20 
  242 ctctcccccgcgcccagcttctccaatgccaatggtggaccggcatcgcccagcatatcg 
      L  S  P  A  P  S  F  S  N  A  N  G  G  P  A  S  P  S  I  S  40 
  302 acatctcccttcaccattggctcaagcaacaccaccagcttgagtacctcccccacccag 
      T  S  P  F  T  I  G  S  S  N  T  T  S  L  S  T  S  P  T  Q  60 
  362 tacccccccagccacccactgtccggctccaagcacctctgctccatatgtggtgaccgg 
      Y  P  P  S  H  P  L  S  G  S  K  H  L  C  S  I  C  G  D  R  80 
   
422 gcctcaggcaaacactatggcgtgtacagttgtgaagggtgcaaggggttcttcaagcgg 
      A  S  G  K  H  Y  G  V  Y  S  C  E  G  C  K  G  F  F  K  R  100 
  482 acagtgcgcaaggacctgacatatgcctgtcgagaagagaggtcatgcaccatcgacaag 
      T  V  R  K  D  L  T  Y  A  C  R  E  E  R  S  C  T  I  D  K  120 
  542 agacagaggaaccgttgccagtattgccggtaccagaagtgcttgtccatggggatgaag 
      R  Q  R  N  R  C  Q  Y  C  R  Y  Q  K  C  L  S  M  G  M  K  140 
  602 agagaagcggtccaggaggaacgtcagaggacaaaaggtgacaaaggagacggagacaca 
      R  E  A  V  Q  E  E  R  Q  R  T  K  G  D  K  G  D  G  D  T  160 
 
  662 gagtcctcctgtggcgctatctccgacatgcccatcgccagcattcgtgaggccgagctc 
      E  S  S  C  G  A  I  S  D  M  P  I  A  S  I  R  E  A  E  L  180 
  722 agtgtggatcccatcgatgagcagccactggaccaaggggatgtggtaagcaatatctgc 
      S  V  D  P  I  D  E  Q  P  L  D  Q  G  D  V  V  S  N  I  C  200 
 
  782 caggcagctgatcgacatctggtgcagctggtggagtgggccaaacatatcccacacttc 
      Q  A  A  D  R  H  L  V  Q  L  V  E  W  A  K  H  I  P  H  F  220 
  842 acagaccttcccatagaagaccaagttgtattactcaaggctggctggaatgagctgctc 
      T  D  L  P  I  E  D  Q  V  V  L  L  K  A  G  W  N  E  L  L  240 
  902 attgcttcattctcacaccgcagcataggagtggaggatggcattgtgctggccacaggc 
      I  A  S  F  S  H  R  S  I  G  V  E  D  G  I  V  L  A  T  G  260 
  962 cttgtggtgcacagaagtagtgctcaccaggctggggtgggagccatatttgaccgtgtc 
      L  V  V  H  R  S  S  A  H  Q  A  G  V  G  A  I  F  D  R  V  280 
 1022 ttatccgagctggtgtccaagatgaaagaaatgaagatggataagacagaactgggttgt 
      L  S  E  L  V  S  K  M  K  E  M  K  M  D  K  T  E  L  G  C  300 
 1082 ctccgtgccattgtcctgttcaacccagatgccaaaggagtgaactgctgcagcgatgtg 
      L  R  A  I  V  L  F  N  P  D  A  K  G  V  N  C  C  S  D  V  320 
 1142 gagatcctgcgtgaaaaagtgtatgcagcccttgaggagtacacccgcaccacctaccca 
      E  I  L  R  E  K  V  Y  A  A  L  E  E  Y  T  R  T  T  Y  P  340 
 1202 gacgagcccggccgcttccccaagctgctgctgcgactcccatcactcaggtccatcggg 
      D  E  P  G  R  F  P  K  L  L  L  R  L  P  S  L  R  S  I  G  360 
 1262 ctcaagtgtcttgaatacctcttcttcttcaagctcattggagacacacccctggatagc 
      L  K  C  L  E  Y  L  F  F  F  K  L  I  G  D  T  P  L  D  S  380 
 1322 tacttgatgaaaatgctggtggacaacccaagtcccagcaacacctcccccaccagctag 













+15-nt insert within DBD
T
 of CasRXR1a (JQ771940) and CasRXR2a (JQ771942) 
   gtaggggcagtagag 
   V  G  A  V  E  
(C) 
+135-nt insert within LBD
L
 of CasRXR2 (JQ771941) and CasRXR2a 
            gtgaggcttgtcaaccattgtcaagttccactggcagcaccacagaccagt 
   V  R  L  V  N  H  C  Q  V  P  L  A  A  P  Q  T  S 
   gatataagtgaaaagagtagctttgccagtagctttgcattaccttttcat 
   D  I  S  E  K  S  S  F  A  S  S  F  A  L  P  F  H   
   tctgtcagtgaagttaacaacgttaatcaagtggatgtg 
   S  V  S  E  V  N  N  V  N  Q  V  D  V  
 
Figure.16  A) Full-length sequence of CasRXR1 and its putative regulatory elements 
analyzed by Regulatory RNA analysis program [105]; grey highlight = uORF; line = IRES; bold 
line = DBD and LBD; and triangles = insertion sites.  B) 15-nt insert in DBD
T
 of CasRXR1a and 
CasRXR2a, and C) 135-nt insert in LBD
L
 of CasRXR2 and CasRXR2a.  The numbers on the left 
designate the nucleotides whereas those on the right refer to the amino acid residues encoded in 
the above nucleotides. 
 
 



































Figure.17.  (A) A multiple sequence alignment of putative aa sequences of CasRXR isoforms.  
Alphabets in blue and magenta represent DBD and LBD, respectively.  Grey highlight indicates 
the insertion fragment.  Glycosylation sites are highlighted in yellow (YinOYang), and 
phosphorylation sites are marked with hexagons (NetPhos 2.0 Server).  (B) Schematic diagrams 
show structural variations in the compartmentalization of four isoforms.   
 
 
2.3.2.2.  Post-translational modification predicted in CasRXR  
 
The four encoded CasRXR proteins were examined for putative O-linked 
glycosylation and phosphorylation (Fig. 17 A).  The highest number of glycosylation 
sites is predicted at the AF1 domain (19 to 22 aa residues), followed by the AF2 domain 
(5 aa residues) and LBD (2 to 6 aa residues).  No glycosylation site is predicted in the 
DBD or the HR.  In contrast, phosphorylation sites are found in the LBD (10 to 16 aa 
residues), the AF1 domain (9 aa residues), the DBD (5 aa residues), the AF2 domain (4 
aa residues), and the HR (1 aa residue).  The number of the predicted sites in each 




Table.6.  Post-translational modifications in CasRXR: O-linked glycosylation predicted by 
YinOYang 1.2 and phosphorylation predicted by NetPhos 2.0 Server 
(http://www.cbs.dtu.dk/services/) 
 
 Isoforms O-linked glycosylation (residues) Phosphorylation (residues) 
  AF1 DBD HR LBD AF2 AF1 DBD HR LBD AF2 
CasRXR1 22 0 0 2 5 9 5 1 10 4 
CasRXR1a 22 0 0 2 5 9 5 1 10 4 
CasRXR2 19 0 0 6 5 9 5 1 16 4 
CasRXR2a 19 0 0 6 5 9 5 1 16 4 
 
 
2.3.2.3.  Relationship of arthropod USP/RXR 
The relationship of the four putative CasRXR shows a similar pattern to that of 
CasEcRs in which two clades are generated: one for crustaceans and the other for insects, 
having human RXR-β as an outgroup (Fig. 18).  CasRXRs are most closely related to C. 




Figure.18.  A phylogram of RXR/USP sequences in arthropods analyzed by Phylogeny.fr with 
human RXR-β (AAB24275.1) as the out-group.  A. aegyptii (AeaRXR: AAG24886.1), A. 
mellifica (ApmUSP: NP_001011634.1), B. mori (BomUSP: NP_001037470.1), C. sapidus 
(CasRXR: HQ630860, JQ771940, JQ771941, JQ771942), C. maenas (CamRXR: ACG63787.1, 
ACG63788.1), C. pugilator (CepRXR: AAC32789.3), C. crangon (CrcRXR: ACO44671.1, 
ACO44668.1, ACO44669.1, ACO44670.1) , D. magna (DamRXR: ABF74729.1) , D. 
melanogaster (DrmUSP: AAF45707.1), G. lateralis (GelRXR: AAZ20368.1, AAZ20369.1, 
AAZ20370.1, AAZ20371.1, AAZ20372.1, AAZ20373.1, AAZ20374.1), H. americanas 
(HoaRXR: AEA29832.1), M. japonicus (MajRXR: BAF75376.1), T. castaneum (TrcUSP: 





2.3.2.4.  Computational prediction and structural modeling of 
CasRXR  
 
The secondary structure of the four CasRXR isoforms obtained was analyzed using 
PREDATOR 2.1.2.  All four CasRXR isoforms (Table.7) contain three and six helices 
(H) in the DBD and the LBD, respectively, and two β sheets (E) in the DBD.  However, 
the 45-aa insert found in the LBD
L
 of CasRXR2/CasRXR2a forms two more β sheets.  
The other domains (AF1, HR, and AF2) were not predicted to contain either H or E 
structures.   
In order to predict the 3-dimentional (3D) structure of the four CasRXR isoforms, 
crystal structures of other USPs/RXRs are required for converting the CasRXR into the 
PDB format.  Base on the PDB format of all four CasRXR isoforms using Bemisia tabaci 
and T. castaneum as references, their PDF are started after the insert site in the LBD (Fig. 
17 B).  Therefore, there is no difference among the four CasRXR isoforms when they are 
analyzed for structural simulation. 
 
Table. 7.  Secondary structure of deduced aa sequences CasRXR predicted by PREDATOR 
2.1.2. H: helix, E: β-sheet, AF1: activation function-1, DBD; DNA-binding domain, HR: hinge 







AF2   H E H E 
CasRXR1 - 3 2 - 6 7 - 
CasRXR1a - 3 2 - 6 7 - 
CasRXR2 - 3 2 - 6 9 - 




2.3.2.5.  Genomic arrangement of CasRXR gene 
The genomic arrangement of CasRXR was mapped from the alignment of 
overlapping sequences obtained from endpoint PCR assays of genomic DNA amplication 
with different pairs of gene specific primers.  Exon-intron boundaries are located by 
aligning all sequences obtained from genomic DNA amplications against the full-length 
cDNA of CasRXR (Fig. 19).  The analyses of some intronic sequences have not been 
completed yet.  Thus far it was revealed that the full length cDNA of CasRXR is derived 
from eight exons and seven introns with a total size of approximately 6 kb.  Exon 1 and 
exon 2 form the AF1 domain, exon 3 and a partial exon 4 generate the DBD, exon 4 
spans from the DBD to the HR, while exons 5-8 encode the LBD and the AF2 domain.  
Variations by insertion (+5 aa and +45 aa residues) are found in exons 4 and 5 that are 
encoding for the DBD and the LBD, respectively.   
 
 
Figure.19.  Genomic map and arrangement of CasRXR constructed by sequence analysis and size 
comparison from PCR amplification using cDNA and genomic DNA.  The red vertical lines 







Exon 1                    2                3           4                  5               6             7           8
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2.3.3.  Expression patterns of CasEcR and CasRXR during the molt 
cycle  
 
2.3.3.1.  Eyestalk (ES)  
 Transcript levels of overall CasEcR and CasRXR isoforms are different during the 
molt cycle in that the former levels are molt-stage dependent, with lower expression at 
intermolt and higher expression at premolt, whereas the latter remains constant.  The 
expression levels of CasRXR isoforms appear to be greater than those of the CasEcRs 
(Figs. 20 C-D and A-B, respectively).  In detail, the expression of CasEcR1 is the highest 
among four isoforms, followed by expression of CasEcR2, CasEcR2a and CasEcR1a 
(Fig. 20 A).  The expression of CasEcR1 is constant and high throughout the molt cycle, 
while CasEcR2 gradually increases as the molt cycle proceeds.  CasEcR1a and 
CasEcR2a are near the detection limit during the molt cycle.  CasRXR1 is found to be the 
major isoform, followed by CasRXR1a and CasRXR2, while the longest form 






Figure. 20.   Temporal expression of the four isoforms of CasEcR (A) and CasRXR (C) in 
eyestalk ganglia (ES) during the molt cycle using an end-point PCR assay.  For each molt stage, 
three cDNA samples obtained from different animals were amplified along with the reference 
gene (AK= arginine kinase).  The relative intensity in (B) and (D) was normalized using the 
ImageJ software program [109].  (B) CasEcR transcripts: diamond = CasEcR1, rectangular = 
CasEcR2, triangle = CasEcR1a, circle = CasEcR2a (D) CasRXR transcripts: diamond = 
CasRXR1, circle = CasRXR2, triangle = CasRXR1a, regtangular = CasRXR2a; C4 = intermolt, D0 
= early premolt, D1 = premolt, D2 = mid premolt, and D3-4 = late premolt.  The p value analyzed 
by One-way ANOVA with post test (The p value *, p<0.05) 
 
 
2.3.3.2.  Y-organs (YO)  
 The transcript levels of CasEcR and CasRXR isoforms in the YO, shown in their 
band intensities are much higher than those found in the ES.  YO at C4 to D4 stages have 
constitutively strong expression of almost all of CasEcR-CasRXR isoforms, except for 
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and D2 stages are higher than the rest of the molt stages.  CasRXR2a expression is highest 
at the early premolt (D0-D1) compared to all the other stages (Fig. 21).   
 
Figure. 21.  Temporal expressions of four isoforms of CasEcR (A) and CasRXR (C) in Y-organs 
(YO) during a molt cycle using an end-point PCR assay.  In each molt stage, three cDNA samples 
obtained from different animals were utilised along with the reference gene (AK = arginine 
kinase).  The relative intensity in (B) and (D) is converted by ImageJ program [109].  (B) CasEcR 
transcripts: diamond= CasEcR1, rectangular = CasEcR2, triangle = CasEcR1a, circle = 
CasEcR2a (D) CasRXR transcripts: diamond = CasRXR1, circle = CasRXR2, triangle = 
CasRXR1a, regtangular = CasRXR2a.   C4= intermolt, D0 = early premolt, D1 = premolt, D2 = mid 
premolt, and D3-4 = late premolt.   














































































2.3.4.  Regulatory elements in untranslated regions (UTR) of 
arthropod EcR and RXR/USP 
 
Since the 5´UTRs of CasEcR and CasRXR contain translational regulation sites, we 
further examined whether this is a common feature in the sequences of other arthropod 
EcR and RXR/USP.  EcR sequences contain uORF as a common element in the 5´UTR, 
where crustacean EcRs have one to two uORF, while those of insects display one to six 
uORFs (Table 8).  In both insects and crustaceans, when the 5´UTR has more than one 
uORF, the last uORF overlaps with the mORF.   
Both crustacean and insect uORFs encode a short peptide sequence ranging from 6 
to 51 residues.  In C. pugilator, the uORF encodes a either hexapeptide (MALAFT) or a 
tetradecapeptide (MIPPLAASPPTNG), while those of T. japonicus and M. japonicus are 
predicted for a nonapeptide (MLAIKHLLT) and a decapeptide (MGERGRGDQD), 
respectively.  These peptides encoded in the uORF(s) are predicted for putative roles, but 
none has functions relating to the Ecds.  The 3´UTR of crustacean EcRs do not contain a 
cytoplasmic polyadenylation element (CPE), while those of insects have CPEs that are 
arranged in tandem repeats (Table 8). 
Table 9 lists the IRES and uORF predicted in the 5´UTR of RXR/USP.  Crustacean 
RXRs contain a single IRES site and/or one uORF, while the insect/arachnid RXR/USP 
encodes more than one IRES and uORF.  Similarly, when these encoded peptides were 










IRES (n) uORF (n) CPE (n) 
Crustaceans    
C. sapidus (HQ630857) 2 2  
C. pugilator (AF034086.2) 1 1  
D. magna:-  AB274824.1 1   
                    EF363705.1 1   
T. japonicus (GQ351503.1) 1 1  
M. japonicus (AB295492.1)  1  
    
Lepidoptera/Diptera    
A. aegypti:- AY345989.1 2 4  
                  AAU02021 1 4 tandem 
B. mori:- NM_001043866.2 1   
              NM_001173377.1 2 1 1 
D. melanogaster:-NM_001169590.1) 1 5 tandem 
                NM_165464.2 1 3  
                NM_165465.2 1 5  
                M74078.1 1 5 tandem 
                AB274824.1 1   
 L. cuprina (LCU75355)  3 tandem 
P. interpunctella (AY489269.2) 7 5 tandem 
M. sexta (MSU19812 ) 1 1  
A. albopictus (AF210733.1) 3 5 tandem 
C. fumiferana (AF092030.2) 2 1 tandem 
A. silvatica (GQ281317.1) 2 1  
B. coprophila: GQ427083.1 1 3 tandem 
                       GQ427082.1 2 4 tandem 
O. fuscidentalis (EF667891.1) 1 1  
P. xylostella (EF417852.1) 1 1  
C. capitata (AJ224341.1) 1 1 tandem 
C. suppressalis (AB067812.1) 1 1  
H. virescens (Y09009.1) 1 1  
    
Arachnida/Chilopoda    
A. americanum: AF020188.1 1 1  
                          AF020187.1 4 10  
 L. australasiae (AB297929.1)  1  
O. moubata (AB191193.1) 1 2  
    
Coleoptera/Hymenotera/Hemiptera/Orthoptera    
T. emma (HQ131915.1) 1 4  
N. vitripennis (NM_001159357.1) 1   
A. mellifera (NM_001159355.1) 1   
L. migratoria (AF049136.1) 1   
C. japonicus: AB296081.1  1 tandem 
                      AB296080.1 2 6 tandem 
B. germanica (AM039690.1) 1 1 tandem 
L. decemlineata: AB211192.1 1 2  
                           AB211191.1  3  
T. molitor (Y11533.1) 3 3   
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IRES (n) uORF (n) CPE (n) 
Crustacean    
C. sapidus (HQ630860) 1 1  
C. maenas (EU683888.1, EU683889.1) 1  
D. magna (DQ530508.1)  1  
M. japonicus (AB295493.1)  1 tandem 
    
Lepidoptera/Diptera    
S. littoralis (HM445735.1) 1 1  
H. armigera (EU526832.1) 1 1  
B. mori (NM_001044005.1) 1 1 tandem 
M. sexta (MSU44837) 2 2  
A. aegypti: AF305213.1 3 2 tandem 
                  AF305214.1 1 4 tandem 
D. melanogaster (NM_057433.3) 2 2 tandem 
C. suppressalis (AB081840.1) 3  tandem 
P. interpunctella (AY619987.1) 1   
B. dorsalis (HM195185.1) 1  tandem 
A. silvatica (GQ281318.1) 1   
A. albopictus (AF210734.1) 1   
S. exigua (EU642475.1) 1 2  
    
Arachnida    
L. australasiae (AB297930.1) 1 2  
O. moubata (AB353290.1) 1  1 
A. americanum (AF035577.1, AF035578.1) 1  tandem 
    
Coleoptera/Hymenotera/Hemiptera/Orthoptera    
C. fumiferana (AF016368.1) 1 2 tandem 
N. vitripennis: XM_003426091.1 5 5 tandem 
                       XM_001605769.2 5 4 tandem 
L. migratoria (AY348873.1) 1 1 tandem 
T. molitor (AJ251542.1) 2 2 tandem 
T. castaneum (NM_001114294.2) 2 3 tandem 
B. impatiens XM_003484414.1  1 2  
                     XM_003484415.1 1 1  
A. pisum (NM_001161668.1)    1 
B. germanica (AJ854490.1)    
A. mellifera (NM_001011634.2)   tandem 
G. firmus (GU201493.1) 1 1 tandem 
B. terrestris (XM_003397944.1) 1 1  







2.4.  Discussion 
2.4.1.  Isolation of cDNAs of C. sapidus EcR and sequence analyses 
Since EcR and RXR mediate the signaling of Ecds by acting as transcription factors 
of Ecd-responsive genes, expression patterns of these two genes in ES and YO, where 
MIH/CHH and Ecd are produced, respectively, may elucidate a regulatory relationship 
between these molecules at various molt stages.  
The four isoforms of CasEcR are similar in their deduced aa sequences except for 
HR and the LBD.  The HR regions are known to affect their molecular flexibility and 
ligand-binding affinity.  The 27-aa insert (CKSKGPSPACDMQFKNLVDTPSIVQTP) in 
the HR
i
 of CasEcR1a/CasEcR2a contains four residues of Pro.  Interestingly, Pro is 
reported to prevent conformation changes within the molecule [110,111].  Thus, it is 
likely that the rotation between the DBD and the LBD of the CasEcR1a/CasEcR2a 
isoforms may be more rigid than that of CasEcR1/CasEcR2.  Generally, conformational 
changes in whole molecule are induced by ligand binding at the LBD [49,56,112-114] 
but these mechanisms may be inhibited by the insert fragment in HR
i
 of 
CasEcR1a/CasEcR2a.  In addition, post-translational prediction of the putative CasEcR 
revealed that the HR
i
 contains a greater number of potential phosphorylation and 
glycosylation sites, indicating a greater steric hindrance.  As a result, 
CasEcR1a/CasEcR2a might be more recalcitrant to the transduction of Ecd signals than 
CasEcR1/CasEcR2.     
In silico structural analyses revealed that there are differences between the LBD 
of CasEcR1/CasEcR1a and CasEcR2/CasEcR2a.  The LBD of CasEcR2/CasEcR2a, 
which is composed of more hydrophobic aa residues, may generate a favorable site for 
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Ecd binding.  This structural model is consistent with the post-translational prediction 
which shows that the LBD of CasEcR1/CasEcR1a seems to be more negatively charged 
resulting from phosphorylation.  It is reasonable to suggest that CasEcR2/CasEcR2a may 
show a greater affinity to Ecd than CasEcR1/CasEcR1a.  All together, each CasEcR 
isoform presents somewhat different molecular properties which may affect the level of 
signal transduction.  Considering steric hindrances on the HR and overall Ecd-binding 
affinity, the ability to transduce the Ecd into a transcriptional response may be predicted 
in the following order: CasEcR1~CasEcR2 > CasEcR1a~ CasEcR2a.   
The variation in the HR and LBD is also found in the isoforms of EcR of other 
decapod crustaceans.  Putative alternative splicing sites are located in the HR and/or the 
LBD as in C. crangon, H. americanus, M. japonicus, N. integer, and U. pugilator 
[97,115-118].  Pro residues are generally included in the insert, and isoforms derived 
from these aa substitution can be more hydrophobic than the others, as found in the LBD 
of NeiEcR and HoaEcR (NeiEcR2>NeiEcR1 and HoaEcRa>HoaEcRb: reanalyzed by 
PyMol).  Over all, it appears that the crustacean EcR isoforms share common features of 
kink formations either in the HR (C. sapidus, H. americanas, M. japonicus, and U. 
pugilator) or the LBD (C. crangon and N. integer), and/or hydrophobic fields in the LBD 
(C. sapidus, N. interger, and H. americanas).  On the other hand, insect and arachnid EcR 
isoforms contain variable regions in the AF1 domain where other transcription factors, 
co-activators, and/or co-repressors can bind [49].  In the AF1 domain, insertions and/or 
aa substitutions are common isoform progenitors in D. melanogaster, A. mellifica, A. 
pisum, N. vitripennis, T. castaneum, N. lugens, and A. aegypti [98,99,119-126,127 ].  It 
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has been found that these variations result from an alternative splicing in the exons 
encoding the A/B domain [125].   
In regards to the distinct differences in EcR-isoform formation between crustaceans 
and other arthropods, it can be deduced that hormonal systems in crustaceans and 
insects/arachnids are different.  This phenomenon might result from different types of 
Ecds circulating in the hemolymph as has been reported [1,11,34,43,128,129].  Moreover, 
the hormonal interactions in crustaceans seem to be more complicated than those of 
insects/arachnids e.g. the number of possible interactions by MIH/CHH.  Therefore, a 
cascade of hormonal responses to Ecd signals in insect systems cannot be used to explain 
crustacean systems.  
 
2.4.2.  Isolation of C. sapidus RXR and sequence analyses 
RXR is an obligatory partner of EcR during Ecd signal transduction. Therefore, 
expression patterns and characterization of CasRXR are required for understanding Ecd 
responses in C. sapidus.  The different sizes and locations of the inserts create four 
different CasRXR isoforms.  The 45-aa insert in the LBD
L
 of CasRXR2 and CasRXR2a 
contains three Pro residues that may introduce a kink in this domain, likely hindering 
accessibility to ligand(s) as predicted above in CasEcR.  The actions of CasRXR to 
transduce Ecd signal cannot be applied because 1) RXR itself does not bind to Ecd in the 
heterodimer of EcR-RXR, and 2) a cognate ligand for crustacen RXR/USP has yet to be 
identified [103,130-132].  However, it has been reported that the different isoforms of 
RXR display their surface residues differentially which can affect the ability or EcR to 
transduce the Ecd signal [131].  Crustacean RXRs including CasRXR share a distinctive 
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feature with the location of inserts that contain many Pro residues.  As stated above, 
structural variation in RXR isoforms provided by these inserts may bear some fucntinal 
significance in flexibility of the LBD.  Interestingly, the variations of insect isoforms are 
different and more diverse than those of crustaceans. The majority of insect isoforms vary 
in the AF1 domain, as those found in N. vitripennis (accession: XM_003426091.1, 
XM_001605769.2), A. aegypti, and T. castaneum [125].  Isoforms of L. peregrinus show 
two different inserts, similar to crustaceans [133].  This finding supports the hypothesis 
that crustaceans have hormonal systems different from insects [134].   
 
2.4.3.  Spatio-temporal expressions of C. sapidus EcR-RXR  
 Every crustacean tissue including ES and YO can be a target for Ecds 
[123,135,136].  Because ES and YO produce counter-acting hormones that regulate 
molting, expression patterns of CasEcR and CasRXR might differ in these two tissues.    
 
2.4.3.1.  Eyestalk ganglia (ES) 
 The ES, containing the ganglia responsible for MIH/CHH synthesis and secretion, 
is proposed to have responses to the Ecd changes during a molt cycle [11,23].  The 
CasEcR-CasRXR complex in ES may be sensitive to Ecd in the hemolymph.  CasEcR1 is 
the major isoform that is constitutively expressed throughout the molt stages, while the 
CasEcR2 gradually increases as the molting progresses.  This finding is consistent with 
the predicted activity of CasEcR isoforms that the CasEcR2 seems to be the most 
proficient at both binding and transducing Ecd signals.  Therefore, up-regulation of 
CasEcR2 during the premolt might result in the increase of trans-activation of the Ecd-
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responsive genes during this stage.  In the ES, only CasRXR2a, the form predicted to 
have an altered heterodimer interface and flexibility, is reduced during the premolt as 
compared to the intermolt.  This raises the possibility for the other CasRXR isoforms to 
form a heterodimer with CasEcR.  
 In addition, it has been reported that the unliganded EcR-USP/RXR heterodimer 
can act as a silencer or repressor for many genes [28,46,49,107,137-140]; therefore, Ecd-
responsive genes including MIH might not be activated during the intermolt.  However, 
this hypothesis contradicts the actions of MIH/CHH at the intermolt in which the 
inhibitory actions of MIH/CHH on molting are highest, so MIH/CHH should be highly 
secreted into the hemolymph [141].  There are possible hypotheses to explain this 
contradiction: 1) CasRXR might form homodimer or heterodimer with other NRs to 
transactivate MIH, and 2) high levels of MIH/CHH are stored from the previous premolt 
and constantly secreted during the next intermolt [25,88,142].   In addition, the 
knowledge that YO during the intermolt have the highest responsiveness to the 
MIH/CHH signal needs to be considered [14,19,25,92,141,143].  Although it is possible 
that the homodimer of CasRXR might stimulate MIH transcription during intermolt, 
cognate ligands are required for releasing CasRXR from its inactive stage [56].  
Therefore, this hypothesis remains questionable.  During the premolt when ecdysteroid 
titers are increased, dimerization of CasRXR might be switched to a CasEcR-CasRXR 
heterodimer resulting from the binding of ligand [144,145].  These activated CasEcR-
CasRXR complexes could stimulate the cascade of downstream genes including EcR 
itself [112] and MIH as has been proposed [11,22], resulting in an increase in MIH 
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production during the premolt.  However, further experiments need to be performed to 
validate this assumption.   
 
2.4.3.2.  Y-organs (YO) 
 YO, in which Ecds are produced and secreted, have irregular activities during the 
molt cycle.  Ecds are able to generate both positive and negative feedbacks on the YO 
[146]. Therefore, it is suggested that different CasEcR-CasRXR complexs may transmit 
the Ecd signals during both early and mid premolt.  In this study, it was found that 
CasEcR1a transcripts, the isoform predicted to be the least effective in transducing Ecd 
signals, are increased during the mid premolt (D1-D2).  This increase in CasEcR1a 
transcripts may increase the ratio of poorly binding forms within a pool of CasEcR-
CasRXR complexes.  As a result, feed-forward interactions of Ecd on YO through 
CasEcR-CasRXR may be switched, and ecdysteroidogenesis would be reduced.  
However, to prove this hypothesis, further experiments need to be performed. 
 Expression levels of CasEcR and CasRXR in the YO are comparable throughout 
the molt cycle; therefore, it is suggested that CasEcR and CasRXR are constitutively 
bound as a heterodimer complex.  However, the expression of CasEcR and CasRXR in 
this study was assayed by end-point PCR. Therefore, the exact transcript levels of each 
isoform are required.   
 
2.4.4.  Post-transcriptional regulations 
 Genes encoding for growth factors, transcription factors and their receptors are 
normally transcriptionally regulated by cis-regulatory elements in the 5´UTR 
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[60,147,148].  The existence of IRES and uORF in the 5´UTR of CasEcR and CasRXR 
suggests that the transcripts of these two genes may not directly represent the expression 
at the protein level.  The IRES presenting in both CasEcR and CasRXR may facilitate 
translational initiation during cellular stresses [75].  However, the relative positions of 
IRES and uORF need to be considered because the uORF functions to suppress 
translation as has been previously reported [149-156].  In the CasEcR, two IRES are 
located upstream of uORF whereas they occur downstream in CasRXR.  This 
arrangement may affect the overall effects of IRES and uORF, in which the relative 
downstream uORF may suppress translation better than the upstream one because the 
IRES acting as the ribosome binding site can recruit the initiation machinery to the 
mRNA in a cap-independent manner, and the scanning ribosome may not complete 
initiation if it encounters the downstream uORF.  This could be the case for the mRNA of 
CasEcR.  Moreover, the second frame of the uORF in the CasEcR overlaps with the 
mORF, resulting in a more effective translational suppression of the mORF.  Therefore, it 
is suggested that the CasEcR may have more pronounced post-translational control than 
the CasRXR.   
 This is the first time in arthropods that the cDNA sequences of EcR and RXR/USP 
have been analyzed for post-transcriptional control and it shows that the occurrance of 
IRES and uORF is conserved among arthropod EcR and RXR/USP genes.  This supports 
the hypothesis that CasEcR and CasRXR may be subjected to post-transcriptional control 
through elements in the 5´UTR.  In order to determine both stimulating and suppressing 




3.  CHAPTER 3.  General conclusions and future studies 
 The molt cycle in the C. sapidus is resulted of interactions between crustacean 
hyperglycemic hormone (CHH) neuropeptide family: CHH/MIH and Ecd hormones.  It is 
clearly stated that CHH and MIH have inhibitory effects on the YO, and the YO show 
differential responses to the CHH neuropeptides during the molt cycle.  The YO at the 
intermolt stage exhibits the greatest inhibitory response to the MIH and CHH, but at 
premolt stage it exhibits a reduced response.    
Previous studies suggest that a crosstalk(s) between MIH/CHH and Ecds may 
determine a molt stage and regulate molting as a cycle.  Suppression of 
ecdysteroidogenesis by MIH/CHH, particularly in vitro, is well established, but the 
feedback regulation of Ecds on the MIH/CHH production in the ES remains to be further 
studied.  Ecds transduce signals by binding to the receptors of transcription factors.  
Thus, expression levels of the receptors in these tissues may correlate to the overall 
response to the Ecd signals.  In this study, cDNA sequences encoding for the ecdysone 
receptor (EcR) and the retinoid-X receptor (RXR) of C. sapidus (CasEcR-CasRXR) were 
isolated and characterized for their significant properties in silico.  It was found that C. 
sapidus expresses four putative isoforms of CasEcR and CasRXR.  EcR is especially 
important since it is known to bind directly to the Ecds.  Two putative CasEcR isoforms 
(CasEcR1a/CasEcR2a) have an insert in the hinge region (HR) that lies between the LBD 
and the DBD.  This insert fragment contains four residues of Pro that may generate steric 
hindrance which can interfere with conformational changes and can result in inefficient 
signal transduction of Ecd.  In addition, the different hydrophobic fields of 
CasEcR1/CasEcR1a and CasEcR2/CasEcR2a may differentially affect binding to the 
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several forms of circulating Ecds which occur during the molt cycle.  It was found that 
during late premolt, PonA is the major Ecd circulated in the hemolymph following by 
20HE, and the former is also more hydrophobic than the latter.  Therefore, it is predicted 
that the CasEcR2/CasEcR2a containing more hydrophobic residues in the LBD, may be 
responsible for binding with PonA, while CasEcR1/CasEcR1a may be more suitable for 
20HE.  The CasRXR, serving as a partner for CasEcR, appears to have variations 
consisting of an inserted fragment at the T-box within the DBD and at the anterior of the 
LBD.  Both inserts are predicted to have effects on the dimerization of CasRXR to the 
CasEcR partner.   
CasEcR expressions in both ES and YO are molt-stage dependent.  In the ES, the 
transcript levels of CasEcR1 and CasEcR2 were increased during premolt in which the 
levels of circulating Ecds are high.  This finding is consistent with the predicted 
properties of CasEcR1 and CasEcR2 that are able to transmit the Ecd signals better than 
CasEcR1a and CasEcR2a isoforms.  It suggests that Ecds may able to induce the 
expression of their receptor for mediating the signals and other Ecd-responsive genes 
including the CHH neuropeptides in the ES.  For the YO, the expression patterns were 
opposite, in which the CasEcR1a transcripts were suddenly increased during the mid 
premolt.  Predicted to be the least effective form to transmit the Ecd signals, the 
increasing of CasEcR1a may lead to a slowing down of the self-stimulation of Ecds in the 
YO, resulting in reduction of ecdysteroidogenesis.  However, isoform screening in 
CasEcR and CasRXR was measured at the transcript levels, and these patterns may not 
represent the expression in the protein levels because cis-regulatory elements for 
translational control are predicted in their 5´UTRs.  Both CasEcR and CasRXR contain 
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uORF and IRES, and these regulatory elements seem to be phylogenetically conserved 
throughout the Phylum Arthropoda.  The presence of IRES and uORF in the 5´UTR of 
CasEcR and CasRXR appears to facilitate translational initiation during the transient 
stress when the general translational machinery is impaired, such as during the premolt.   
In conclusion, the isolation of cDNA sequences of CasEcR and CasRXR isoforms 
provide fundamental knowledge for further investigation into the roles of Ecds in molt 
cycle regulation.  However, the hypotheses that Ecds signal to ES for the production and 
secretion of the CHH neuropeptide hormones, but slow-down ecdysteroidogenesis in the 
YO requires further experiments.  Transcript levels of CasEcR-CasRXR isoforms during 
the molt cycle need to be determined using quantitative PCR assays, and the direct effects 
of Ecds on the expressions of CasEcR1/CasEcR2 and CasEcR1a in ES and YO, 
respectively, need to be studied.  Moreover, transactivation of EcR/RXR complex upon 
binding to Ecds on the levels of MIH/CHH needs to be examined on its transcription, 
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